CAM
ALXN
CG Asset Management’s Alexion Pharmaceuticals Inc ALXN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2016
Q4 | – | Sell |
-3,750
| Closed | -$460K | – | 153 |
|
|
2016
Q3 | $460K | Buy |
3,750
+300
| +9% | +$36.8K | 0.17% | 100 |
|
|
2016
Q2 | $403K | Sell |
3,450
-1,600
| -32% | -$187K | 0.16% | 95 |
|
|
2016
Q1 | $703K | Sell |
5,050
-1,700
| -25% | -$237K | 0.28% | 79 |
|
|
2015
Q4 | $1.29M | Buy |
6,750
+1,100
| +19% | +$210K | 0.51% | 59 |
|
|
2015
Q3 | $884K | Sell |
5,650
-1,800
| -24% | -$282K | 0.37% | 67 |
|
|
2015
Q2 | $1.35M | Sell |
7,450
-14,150
| -66% | -$2.56M | 0.51% | 57 |
|
|
2015
Q1 | $3.74M | Buy |
21,600
+360
| +2% | +$62.4K | 1.46% | 22 |
|
|
2014
Q4 | $3.93M | Buy |
21,240
+13,465
| +173% | +$2.49M | 1.55% | 24 |
|
|
2014
Q3 | $1.29M | Buy |
7,775
+3,925
| +102% | +$651K | 0.53% | 61 |
|
|
2014
Q2 | $602K | Buy |
3,850
+500
| +15% | +$78.2K | 0.25% | 84 |
|
|
2014
Q1 | $510K | Buy |
3,350
+300
| +10% | +$45.7K | 0.23% | 94 |
|
|
2013
Q4 | $405K | Buy |
+3,050
| New | +$405K | 0.19% | 106 |
|